| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.42 | 1e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |